期刊文献+

^(131)I-nor-β-CIT的制备及其大鼠体内分布 被引量:3

Synthesis, Labelling With ^(131)I and Distributionin Rats of nor-β-CIT
下载PDF
导出
摘要 合成了 2β-甲酯基 - 3β- (4’-碘苯基 )去甲基托烷 (nor-β- CIT)及标记前体 2β-甲酯基 - 3β- (4’- (三丁基锡 )苯基 )去甲基托烷。nor- β- CIT及中间体的 IR、MS、HNMR、旋光分析等鉴定数据与结构相符。由标记前体制备 13 1I- nor- β- CIT,标记率 (80~ 90 ) % ,萃取后放化纯度 >95%。大鼠体内分布表明 ,13 1I- nor- β- CIT能很快进脑 ,且清除较慢 (注药后 5min、30 min和 4 h时脑的放射性摄取比分别为 2 .30、2 .54和 1.2 2 % ID)。丘脑、中脑、海马和额叶表现出较高的放射性摄取 ,注药后约 1h达到最大值 (分别为 1.77、1.78、1.54和 2 .13% ID)。额叶的摄取大于颞叶和顶叶 (1h时的放射性摄取分别为 2 .13、1.92、1.87% ID) ,与 5- carbomethoxy-3β-(4'-iodophenyl)nortropane(nor-β-CIT) and it's labelling precursor 2β-carbomethoxy-3β-(4'-tribuylstannylphenyl)nortropane are synthesized, the chemical structures of nor-β-CIT and it's intermediates are confirmed by IR, MS, HNMR and rotation. The Radiochemical purity of 131 I-nor-β-CIT is over 95% evaluated by HPLC and TLC. Biodistribution in rats indicate rapid uptake and slow clearance of 131 I-nor-β-CIT in brain (2.30, 2.54 and 1.22 %ID respectively at 5, 30 and 240 min after injection). It displays high radiouptake in thalamencephalon, midbrain, hippocampi and frontal lobe, the maximum values are 1.77, 1.78, 1.54 and 2.13 %ID respectively at about 1 hour after injection. The value of uptake in frontal lobe is greater than in temporal lobe and in parietal lobe(2.13, 1.92 and 1.87 %ID), which are consistent with the distribution of serotonin transporter in the brain.
出处 《同位素》 CAS 2001年第1期11-15,共5页 Journal of Isotopes
基金 国家自然科学基金! ( 39770 2 30 ) 卫生部科研基金! ( 98- 1- 32 6 ) 江苏省科委优秀科研骨干人才储备基金 江苏省自然科学基金!
关键词 羟色氨转运蛋白 碘131标记物 神经系 疾病 诊断 脑显像剂 大鼠 体内分布 制备 nor-β-CIT HTT transporter nor-β-CIT ^(131)I labelling distribution in rats
  • 相关文献

参考文献1

二级参考文献7

  • 1 Clark RL, Daum SJ,Gambino AJ, et al. Compounds Affecting the Central Nervous System, 3 β-phenyltropane-2-carboxylicEsters and Analogs [J]. J Med Chem, 1973, 16(11):1 260~1 267.
  • 2 Meltzer PC, Liang AY, Brownell AL, et al. Substituted 3-phenyltropane Analogs ofCocaine: Synthesis, Inhibition of Binding at Cocaine Recogition Sites, and PositionEmission Tomography Imaging [J]. J Med Chem, 1993, 36(7):856.
  • 3 Carroll FI, Yigong Gao, Rahman MA, et al. Synthesis, Ligand Binding, QSAR, andCoMFA Study of 3β-(p-substituted Phenyl) tropane-2β-carboxylic Acid Methyl Ester [J].J Med Chem, 1991, 34(9):2 719~2 725.
  • 4 Neumeyer JL, Shaoyin Wang, Milius RA, et al. [131I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane:High-affinity SPECT Radiotracer of Monoamine Reuptake Sites in Brain [J]. J Med Chem,1991, 34:3 144.
  • 5 Asenbaum S, Brucke T, Pirker W, et al. Imaging of Dopamine Transporters With 125I-β-CITand SPECT in Parkinson's Disease [J]. J Nucl Med, 1997, 38:1~6.
  • 6 Booj J, Tissingh G, Winogrodzka A, et al. Practical Benefit of [123I]FP-CITSPECT in the Demonstration of the Dopaminergic Defict in Parkinson's Disease [J]. EurJ Nucl Med, 1997, 24:68~71.
  • 7李培勇.早期帕金森病^(123)I-β-CIT脑SPECT显像研究[J].中华核医学杂志,1998,18(3):133-135. 被引量:9

共引文献2

同被引文献6

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部